The Latest Cardiac and Vascular News
SAN DIEGO–(BUSINESS WIRE)–Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), today announced the appointment of Janice Lu, M.D., Ph.D., as Chief Medical Officer of Ambrx. Dr. Lu is a distinguished clinical professor of […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, will feature the most recent Impella research and technological advances aimed at improving outcomes for acute myocardial infarction cardiogenic shock (AMICS) patients during the Society for Cardiovascular Angiography and Interventions (SCAI) 2022 Scientific Sessions, May 19 […]
Northwell Health has joined the Cardiometabolic Center Alliance (CMCA) as a charter member, which was founded by Saint Luke’s Mid America Heart Institute in St. Louis, to provide innovative treatment approaches to patients with type 2 diabetes and cardiovascular disease. As a charter member, Northwell will further its ongoing research […]
University Hospitals Harrington Heart & Vascular Institute has developed a novel solution for one procedure affected by the nationwide shortage of contrast dye. Cardiologists at the Cleveland hospital recently were the first to report using cardiovascular magnetic resonance imaging (CMR) for left atrial appendage closure preprocedural planning. Left atrial appendage […]
Results presented at EuroPCR 2022 show notable reduction of blood pressure in patients on and off medications at six months PALO ALTO, Calif.–(BUSINESS WIRE)–ReCor Medical, Inc. (“ReCor”) and Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) a fully owned subsidiary of Otsuka Holdings Co., Ltd., today announced that Dr. Ajay […]
Medtronic adds to SPYRAL HTN Global Clinical Program with late breaking clinical data for SPYRAL HTN-ON MED and GSR-DEFINE DUBLIN and PARIS, May 17, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced data showing the benefits of the Symplicity Blood Pressure Procedure with the Symplicity Spyral™ Renal Denervation […]
The heart failure program is a new model for cardiology practices in managing heart failure, starting with patients in Northeast Florida NEW YORK, May 17, 2022 /PRNewswire/ — Novocardia, a value-based cardiovascular disease care platform, has launched an innovative heart failure program that combines individualized health coaching and remote patient monitoring to improve […]
LITTLE ROCK, Ark., May 17, 2022 /PRNewswire/ — HealthTech Arkansas and MedAxiom have come together to create HeartX, a cardiovascular-focused healthcare accelerator, to facilitate guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market. Applications for the 2022 HeartX cohort are now open, and companies […]
Q3 Medical Devices Bi-Directional Stent, QualiMed Innovative Medizinprodukte GmbH, Winsen, Germany Results Published DUBLIN, May 17, 2022 /PRNewswire/ — Journal of Endovascular Therapy, 2022 (Impact factor 3.487 source Sage Journals) with title “Stents with torsional strength for Superficial Femoral artery disease. The prospective Q3-Registry” by Thieme et al: “The Q3 SELF-EXPANDING stent offers a novel patented Bi-Directional design providing for a new way of flexibility and torsional conformability that is highly durable and crush resistant working in unison […]
ROCKVILLE, Md. , May 17, 2022 /PRNewswire/ — A new position paper published today by the Heart Failure Society of America (HFSA) outlines disparities in healthcare that affect patients with heart failure, including race and ethnicity, socioeconomic factors, and social determinants of health. The statement also presents actions that can be taken to […]
